Contraception utilization in women with pregestational diabetes

Simple item page
dc.contributor.authorWalker, Shannon L.
dc.contributor.authorAnguzu, Ronald
dc.contributor.authorEgede, Leonard E.
dc.contributor.authorPalatnik, Anna
dc.date.accessioned2023-06-07T21:09:16Z
dc.date.available2023-06-07T21:09:16Z
dc.date.issued2022
dc.description.abstractCross-sectional data on women aged 18–44 years from 2011 to 2017 National Survey of Family Growth (NSFG) was analysed. Maternal diabetes was defined as the presence of pre-gestational type 1 or type 2 diabetes. Bivariate and multiple logistic regression analyses were run to evaluate the association between the use of contraception and by contraception type: permanent, long-acting reversible contraception (LARC), other hormonal method, other non-hormonal method, and none, and maternal diabetes status, controlling for relevant covariates. Among the total study sample of 28,454, 1344 (4.7%) had pregestational diabetes. Unadjusted analysis showed women with a history of pregestational diabetes were more likely to use permanent contraception following pregnancy (58.0% vs. 38.7%, p < 0.001) or no contraception (27.2% vs. 24.5%, p < 0.001), but less likely to use LARC (3.4% vs. 11.7%, p < 0.001), other hormonal contraception (4.1% vs. 8.9%, p < 0.001), or other non-hormonal contraception (7.2% vs. 16.4%, p < 0.001). In adjusted analyses, permanent (aOR 1.62, 95% CI 0.72–2.26) remained significant, however the differences were no longer statistically significant: LARC (aOR 0.34, 95% CI 0.12–1.00); other hormonal (aOR 0.61, 95% CI 0.27–1.35); other non-hormonal (aOR 0.59, 95% CI 0.25–1.43); and None (aOR 1.11, 95% CI 0.65–1.89). In this analysis, we found that women with pregestational diabetes were more likely to use permanent contraception methods compared to women without pregestational diabetes; however over a quarter of women with pregestational diabetes did not use contraception between pregnancies.en_US
dc.identifier.citationWalker, S. L., Anguzu, R., Egede, L. E., & Palatnik, A. (2022). Contraception utilization in women with pregestational diabetes. The European Journal of Contraception & Reproductive Health Care, 27(4), 317-321.https://doi.org/10.1080/13625187.2022.2074392en_US
dc.identifier.urihttps://nru.uncst.go.ug/handle/123456789/8902
dc.language.isoenen_US
dc.publisherThe European Journal of Contraception & Reproductive Health Careen_US
dc.subjectPregestational diabetesen_US
dc.subjectContraception utilizationen_US
dc.subjectWomenen_US
dc.titleContraception utilization in women with pregestational diabetesen_US
dc.typeArticleen_US
Files
Original bundle
Now showing 1 - 1 of 1
Thumbnail Image
Name:
Contraception utilization in women with pregestational diabetes.pdf
Size:
1000.52 KB
Format:
Adobe Portable Document Format
Description:
Contraception utilization in women with pregestational diabetes
Download
License bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
1.71 KB
Format:
Item-specific license agreed upon to submission
Description:
Download
Collections
Medical and Health Sciences